X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.nasdaq.com/press-release/incannex-announces-positive-topline-results-from-phase-2-psi-gad1-clinical-trial-of
https://www.fiercebiotech.com/cro/fortrea-inks-deal-australias-incannex-sleep-apnea-drug-trial
https://www.contractpharma.com/contents/view_breaking-news/2022-11-30/incannex-engages-eurofins-to-manufacture-topical-therapeutic-renecann/?widget=listSection
https://www.contractpharma.com/contents/view_breaking-news/2022-11-28/incannex-eurofins-enter-development-mfg-pact-for-addiction-disorder-meds/9769
https://smallcaps.com.au/incannex-healthcare-manufacture-patented-medicated-chewable-anti-addiction-products/
https://www.proactiveinvestors.com.au/companies/news/988901/incannex-healthcare-partners-with-r-d-organisation-curia-to-scale-up-manufacture-of-drug-targeting-traumatic-brain-injury-988901.html
https://www.prnewswire.com/news-releases/incannex-healthcare-quarterly-activities-report-and-appendix-4c-cash-flow-statement-301594276.html
https://www.prnewswire.com/news-releases/incannex-receives-ethics-approval-to-commence-phase-1-clinical-trial-of-multi-use-anti-inflammatory-drug-ihl-675a-301590797.html
https://www.prnewswire.com/news-releases/incannex-to-present-at-the-hc-wainwright-first-annual-mental-health-conference-301575448.html
https://www.prnewswire.com/news-releases/incannex-announces-positive-results-from-phase-2-clinical-trial-investigating-the-effect-of-ihl-42x-for-treatment-of-obstructive-sleep-apnoea-301560782.html
Market Place
Share 
